Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 8NIH 8NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 6CNS 6Thoracic 3Genitourinary 3Gastrointestinal 2Endocrine 2Breast 2Other hematologic neoplasm 1Lymphoid 1Gynecologic 1Dermatologic 1

Conditions

Ovarian Neoplasms 117Uterine Cervical Neoplasms 65Carcinoma, Ovarian Epithelial 64Fallopian Tube Neoplasms 62Endometrial Neoplasms 38Brenner Tumor 22Sarcoma 18Testicular Neoplasms 15Vulvar Neoplasms 12Squamous Intraepithelial Lesions 10Sarcoma, Endometrial Stromal 10Endometrial Adenocarcinoma 10Breast Neoplasms 10Ovarian Germ Cell Cancer 9HIV Infections 9Teratoma 7Sarcoma, Synovial 7Precancerous Conditions 7Osteosarcoma 7Neurofibrosarcoma 7Neuroblastoma 7Melanoma 7Liposarcoma 7Leiomyosarcoma 7Histiocytoma, Malignant Fibrous 7Hemangiosarcoma 7Fibrosarcoma 7Carcinoma, Non-Small-Cell Lung 7Uterine Cervical Dysplasia 6Stomach Neoplasms 6

Interventions

Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Esthesioneuroblastoma, Olfactory × Gynecologic × Clear all
NCT00006036 2020-04-06

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

Canadian Cancer Trials Group

Phase 1 Completed
14 enrolled
CNSGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Nasopharyngeal Neoplasms, Ovarian Neoplasms, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡